Precision BioSciences Inc Sustainability Reports
Precision BioSciences, Inc. operates as a clinical-stage genome editing company. The company utilizes its proprietary ARCUS genome editing platform to develop in vivo therapies designed to cure genetic and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300I5QGRS3BLHZH41
FIGI: BBG008NSBPW2
2 reports from 2022 to 2022
